US Patent Issued to Deutsches Krebsforschungszentrum on July 7 for "Substituted aminothiazoles as DGKzeta inhibitors for immune activation" (German Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,927, issued on July 7, was assigned to Deutsches Krebsforschungszentrum (Germany).

"Substituted aminothiazoles as DGKzeta inhibitors for immune activation" was invented by Norbert Schmees (Berlin), Ulrike Roehn (Berlin), Dennis Kirchhoff (Berlin), Kirstin Petersen (Berlin), Thi Thanh Uyen Nguyen (Berlin), Mareike Grees (Berlin), Nicolas Werbeck (Freiburg, Germany), Ulf Boemer (Glienicke, Germany), Benjamin Bader (Berlin), Detlef Stockigt (Potsdam, Germany), Dirk Kosemund (Berlin), Rienk Offringa (Heidelberg, Germany), Corinna Link (Mannheim, Germany), Katrin Nowak-Reppel (Berlin) and Ulrich Rosentreter (Binnen, Germany).

According to the abstract* released by the U.S. Patent & Tra...